Crestor

Crestor, manufactured by AstraZeneca Pharmaceuticals LP of Wilmington, Delaware, is a cholesterol reducing drug which is part of a class of pharmaceuticals called "statins". Statins reduce cholesterol by reducing a specific enzyme responsible for the synthesis of cholesterol in the body. Crestor has been linked with multiple side effects, including:

Kidney failure and kidney damage
Rhabdomyolysis - which is a life threatening destruction of muscle tissue

The consumer group, Public Citizen, states that the reported kidney problems are 75 times higher with Crestor than with all other drugs in the same class combined. On March 2, 2005, the FDA issued a public health advisory describing changes to the product labels concerning dnagers associated with Crestor and recent study results. Dr. Wolfe from Public Citizen has criticized the action of the FDA as too limited.